Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
15 nov. 2021 08h30 HE
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
28 juil. 2021 10h39 HE
|
Biocodex Canada
MONTREAL, July 28, 2021 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is...
Biocodex Microbiota Foundation lance un appel à propositions au Canada pour financer une étude sur le rôle joué par le microbiome dans la santé et les maladies
28 juil. 2021 10h39 HE
|
Biocodex Canada
MONTRÉAL, 28 juill. 2021 (GLOBE NEWSWIRE) -- Biocodex Microbiota Foundation, organisme fondé par Biocodex et dédié à soutenir des projets scientifiques inspirants qui explorent le microbiome, lance un...
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
01 juil. 2021 08h00 HE
|
Summit Therapeutics Inc.
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research...
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
24 févr. 2021 10h00 HE
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
17 août 2020 11h56 HE
|
Biocodex Canada
MONTREAL, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is...
Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles
15 avr. 2019 09h00 HE
|
Taconic Biosciences
RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOMETM, a first of...
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
01 avr. 2019 11h43 HE
|
Taconic Biosciences
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild...
Taconic Biosciences Expands Microbiome Portfolio
04 mai 2017 15h14 HE
|
Taconic Biosciences
HUDSON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice,...
Taconic Biosciences Expands Microbiome Product and Service Platform
26 avr. 2017 11h03 HE
|
Taconic Biosciences
HUDSON, N.Y., April 26, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free...